• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
73,832.55 -150.63
( -0.20%)
Global Indices
Nasdaq
50,865.93 926.15
(1.85%)
Dow Jones
7,414.60 126.61
(1.74%)
Hang Seng
64,050.08 -129.19
(-0.20%)
Nikkei 225
10,316.43 61.62
(0.60%)
Forex
USD-INR
95.41 -0.12
(-0.12%)
EUR-INR
110.18 0.04
(0.03%)
GBP-INR
127.60 0.17
(0.13%)
JPY-INR
0.60 0.00
(-0.17%)

EQUITY - MARKET SCREENER

Bal Pharma Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524824
INE083D01012
65.3864135
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
BALPHARMA
20
135.04
EPS(TTM)
Face Value()
Div & Yield %
4.24
10
1.41
 

Vaxtex Cotfab standalone net profit declines 40.15% in the March 2026 quarter
May 26,2026
Net profit of Vaxtex Cotfab declined 40.15% to Rs 0.79 crore in the quarter ended March 2026 as against Rs 1.32 crore during the previous quarter ended March 2025. There were no Sales reported in the quarter ended March 2026 as against Rs 5.25 crore during the previous quarter ended March 2025.

For the full year,net profit rose 528.41% to Rs 5.53 crore in the year ended March 2026 as against Rs 0.88 crore during the previous year ended March 2025. Sales rose 112.76% to Rs 11.17 crore in the year ended March 2026 as against Rs 5.25 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales05.25 -100 11.175.25 113
OPM %0-1.90 -16.92-9.71 -
PBDT0.400.90 -56 5.080.51 896
PBT0.400.89 -55 5.060.41 1134
NP0.791.32 -40 5.530.88 528